Clinical Trial Update: Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure [NA]

View source ↗

Summary

A completed safety study of a selective cytopheretic device (SCD) in patients with acute renal failure; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Failure

Drugs mentioned

• SelectAggressive Cytopheretic Device (SCD) (selective cytopheretic device)

Snippet

Sponsor: SeaStar Medical | Conditions: Acute Renal Failure | NA | Status: COMPLETED | Results posted: 2022-03-09